Delivery Order SPE2DB22D3501-SPE2DB23FWF96
Award Date 7/3/23
Potential Completion Date 7/5/23
Potential Value $9.3
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,280 delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The firm fixed price order is valued at approximately $9,280 and calls for delivery to a facility in Conshohocken, Pennsylvania. Amerisourcebergen will fulfill the order as the prime contractor under the agency's pharmaceutical supply vehicle. No subcontractors or set aside designations were specified. The order supports the...
- The Defense Logistics Agency awarded a $9,280 delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The firm fixed price order is valued at approximately $9,280 and calls for delivery to a facility in Conshohocken, Pennsylvania. Amerisourcebergen will perform under the order from July 24-25, 2023 to supply the chemotherapy drug in support of the Defense Logistics Agency's medical supply chain responsibilities within the...
- The Defense Logistics Agency awarded a $9,280 delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location. The order was placed on July 20, 2023 under an existing indefinite-delivery/indefinite-quantity contract vehicle and is to be completed by July 21, 2023. No subcontractors or set aside designations were specified. This...
- The Defense Logistics Agency awarded a $9,280 delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania, with performance spanning July 20 through July 21, 2023. As a top supplier on the DLA's Pharmaceutical Prime Vendor contract vehicle, Amerisourcebergen will deliver the chemotherapy medication to support oncology...
- The Defense Logistics Agency awarded a $9,280 delivery order to Amerisourcebergen Drug Corporation for 50 vials of cisplatin, a chemotherapy drug. Performance will take place at the prime contractor's facility in Conshohocken, Pennsylvania under a firm fixed price arrangement. The order was placed under an existing DLA pharmaceuticals contract vehicle to supply chemotherapy products and services in support of the Military Health System. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $30,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The single order is for 50 vials and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania between July 14 and July 17, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the global supply chain for the U.S. military and...
- The Defense Logistics Agency awarded a $43,620 delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania, with performance spanning July 14 through July 17, 2023. As a top supplier on the DLA's Pharmaceutical Prime Vendor contract vehicle, Amerisourcebergen will deliver the chemotherapy medication to support oncology...
- The Defense Logistics Agency awarded a $9,280 delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The firm fixed price order is to provide 50 milliliters of the chemotherapy medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 20-21, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to...
- The Defense Logistics Agency awarded a $9,280 delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The firm fixed price order is valued at approximately $9,280 and calls for delivery to a facility in Conshohocken, Pennsylvania. Performance will take place between July 24-25, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceuticals and...
- The Defense Logistics Agency awarded a $9,280 delivery order to Amerisourcebergen Drug Corporation for 50 vials of cisplatin, a chemotherapy drug. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania under firm fixed pricing from July 24-25, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to supply chemotherapy drugs and related products in support of the Military Health System. No set aside designation or subcontractors were...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWF96Delivery Order
The Defense Logistics Agency awarded a $9,280 delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The firm fixed price order is valued at approximately $9,280 and calls for delivery to a facility in Conshohocken, Pennsylvania between July 3 and July 5, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this order placed under the DLA's pharmaceuticals supply vehicle to support oncology treatment programs within the Military Health System. No subcontractors or set aside designations were specified.
Generated 12/24/23, 5:08 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9 | 7/3/23 |